Knockdown of EGR1 expression can decrease cisplatin-induced apoptosis in a variety of cancer cells (27–29), while overexpression of this gene sensitizes ovarian cancer cells to cisplatin-induced apoptosis (28). The gene discussed is EGR1; the disease is cancer.